Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Orange High School reverses decision, student will walk at graduation
Program
Tonight at 6: It's blamed for more crashes among NC teens than speed and alcohol combined. WRAL Investigates distracted teen driving.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
49.36
+2.75 (+5.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,469,463
Open
48.80
Bid (Size)
47.05 (1)
Ask (Size)
49.36 (3)
Prev. Close
46.61
Today's Range
48.65 - 49.83
52wk Range
42.63 - 57.82
Shares Outstanding
1,250,690,553
Dividend Yield
3.86%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Today 13:58 EDT
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
Via
Benzinga
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Today 13:45 EDT
SNY earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Performance
YTD
-1.28%
-1.28%
1 Month
-0.16%
-0.16%
3 Month
-1.06%
-1.06%
6 Month
-7.03%
-7.03%
1 Year
-13.68%
-13.68%
More News
Read More
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
Today 10:15 EDT
Via
Benzinga
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Today 9:47 EDT
Via
Benzinga
How Is The Market Feeling About Sanofi?
March 27, 2024
Via
Benzinga
(SNY) - Analyzing Sanofi's Short Interest
March 08, 2024
Via
Benzinga
SNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024
Today 7:53 EDT
Via
InvestorPlace
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
Today 7:31 EDT
Via
Investor's Business Daily
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
Today 6:17 EDT
Via
Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
April 17, 2024
Via
Benzinga
Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years
April 17, 2024
Via
Benzinga
Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
April 17, 2024
Via
Benzinga
Novo Nordisk Arms Wegovy to Be a Triple Threat
April 15, 2024
Via
MarketBeat
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
April 12, 2024
Via
Benzinga
Exposures
Product Safety
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Via
InvestorPlace
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
April 10, 2024
Via
Benzinga
Why Is Auddia (AUUD) Stock Up 192% Today?
April 08, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AIRC Stock Alert: Blackstone Is Taking Apartment Income REIT Private
April 08, 2024
Via
InvestorPlace
Sanofi Layoffs 2024: What to Know About the Latest SNY Job Cuts
April 08, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
April 04, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
March 27, 2024
Via
Benzinga
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
March 26, 2024
Via
Benzinga
To the Moon and Beyond: 7 Stocks With Cosmic Potential
March 14, 2024
Via
InvestorPlace
Passport to Profits: 7 Global Growth Gems to Diversify Your Holdings
March 13, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.